---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-26-038058"
form_type: "8-K"
ticker: "SNTI"
cik: "0001854270"
company_name: "Senti Biosciences, Inc."
filed_at: "2026-05-26T20:02:21+00:00"
generated_at: "2026-05-26T20:05:16.217149+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Senti Biosciences issues $10M convertible notes to Celadon; discloses potential merger with $60M CVR

## Summary
- $10M senior secured convertible notes sold to Celadon Partners; maturity 6 months, 12% default interest rate on event of default.
- Notes convertible into common stock; mandatory exchange upon stockholder approval or CVR closing.
- Potential transaction: Celadon affiliate to merge into Senti Holdings and issue CVR up to $60M tied to SENTI-202 milestones.
- Company to file proxy statement for stockholder vote on potential merger and CVR issuance.
- Registration rights, guarantee, and voting agreements also entered with directors and Celadon.

## SEC filing metadata
- accession: 0001628280-26-038058
- form_type: 8-K
- ticker: SNTI
- cik: 0001854270
- company_name: Senti Biosciences, Inc.
- filed_at: 2026-05-26T20:02:21+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1854270/000162828026038058/0001628280-26-038058-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1854270/000162828026038058/snti-20260520.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-26-038058
- JSON: https://secwatch.observer/filing/0001628280-26-038058.json
- Plain text: https://secwatch.observer/filing/0001628280-26-038058.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.